v3.26.1
REVERSE RECAPITALIZATION - Schedule Of Common Stock Outstanding After Merger (Details) - $ / shares
Jun. 05, 2026
Jun. 04, 2026
Jun. 30, 2026
May 31, 2026
Dec. 31, 2025
Schedule Of Reverse Recapitalization [Line Items]          
Issued and sold (in shares) 7,519,404        
Converted, reverse recapitalization (in shares) 89,083,034        
Common stock, outstanding (in shares) 107,023,243        
Common stock, par value (in usd per share)       $ 0.00001  
Sponsor and Director Co          
Schedule Of Reverse Recapitalization [Line Items]          
Issued during period, acquisition (in shares) 5,810,000        
PIPE Institutional Investor          
Schedule Of Reverse Recapitalization [Line Items]          
Issued and sold (in shares) 6,340,000        
Issued and sold (in usd per share) $ 8.68        
PIPE Institutional Investor | Subscription Agreements          
Schedule Of Reverse Recapitalization [Line Items]          
Issued and sold (in shares) 5,500,000        
Issued and sold (in usd per share) $ 10.00        
PIPE Institutional Investor | Reverse Recapitalization          
Schedule Of Reverse Recapitalization [Line Items]          
Issued and sold (in shares) 750,000        
PIPE Institutional Investor | Letter Agreement          
Schedule Of Reverse Recapitalization [Line Items]          
Issued and sold (in shares) 90,000        
PIPE Sponsor Investor          
Schedule Of Reverse Recapitalization [Line Items]          
Issued and sold (in shares) 1,179,404        
Issued and sold (in usd per share) $ 8.21        
PIPE Sponsor Investor | Subscription Agreements          
Schedule Of Reverse Recapitalization [Line Items]          
Issued and sold (in shares) 929,404        
Redemption price (in usd per share) $ 10.42        
PIPE Sponsor Investor | Reverse Recapitalization          
Schedule Of Reverse Recapitalization [Line Items]          
Issued and sold (in shares) 250,000        
Cantor Advisory Fee          
Schedule Of Reverse Recapitalization [Line Items]          
Issued for services (in shares) 62,118        
Sponsor Members          
Schedule Of Reverse Recapitalization [Line Items]          
Issued during period, acquisition (in shares) 5,710,000        
Director Members          
Schedule Of Reverse Recapitalization [Line Items]          
Issued during period, acquisition (in shares) 100,000        
Series A Common stock          
Schedule Of Reverse Recapitalization [Line Items]          
Converted, reverse recapitalization (in shares) 73,570,292        
Common stock, outstanding (in shares) 91,510,501   91,510,501   18,486,699
Common stock, par value (in usd per share)     $ 0.00001   $ 0.00001
Series A Common stock | Sponsor and Director Co          
Schedule Of Reverse Recapitalization [Line Items]          
Issued during period, acquisition (in shares) 5,810,000        
Series A Common stock | PIPE Institutional Investor          
Schedule Of Reverse Recapitalization [Line Items]          
Issued and sold (in shares) 6,340,000        
Series A Common stock | PIPE Sponsor Investor          
Schedule Of Reverse Recapitalization [Line Items]          
Issued and sold (in shares) 1,179,404        
Series A Common stock | Cantor Advisory Fee          
Schedule Of Reverse Recapitalization [Line Items]          
Issued for services (in shares) 62,118        
Series A Common stock | Legacy Factorial Common Stock Shareholders          
Schedule Of Reverse Recapitalization [Line Items]          
Converted, reverse recapitalization (in shares) 3,081,263        
Series A Common stock | Legacy Factorial Preferred Stock Shareholders          
Schedule Of Reverse Recapitalization [Line Items]          
Converted, reverse recapitalization (in shares) 67,314,957        
Series A Common stock | Legacy Factorial Convertible Notes Shareholders          
Schedule Of Reverse Recapitalization [Line Items]          
Converted, reverse recapitalization (in shares) 2,811,447        
Series A Common stock | Factorial Warrants Shareholders          
Schedule Of Reverse Recapitalization [Line Items]          
Converted, reverse recapitalization (in shares) 362,625        
Series B Common stock          
Schedule Of Reverse Recapitalization [Line Items]          
Converted, reverse recapitalization (in shares) 15,512,742        
Common stock, outstanding (in shares) 15,512,742   15,512,742   15,512,742
Common stock, par value (in usd per share)     $ 0.00001   $ 0.00001
Series B Common stock | Sponsor and Director Co          
Schedule Of Reverse Recapitalization [Line Items]          
Issued during period, acquisition (in shares) 0        
Series B Common stock | PIPE Institutional Investor          
Schedule Of Reverse Recapitalization [Line Items]          
Issued and sold (in shares) 0        
Series B Common stock | PIPE Sponsor Investor          
Schedule Of Reverse Recapitalization [Line Items]          
Issued and sold (in shares) 0        
Series B Common stock | Cantor Advisory Fee          
Schedule Of Reverse Recapitalization [Line Items]          
Issued for services (in shares) 0        
Series B Common stock | Sponsor Members          
Schedule Of Reverse Recapitalization [Line Items]          
Common stock, par value (in usd per share) $ 0.0001        
Cartesian Growth Corporation (“CGC”)          
Schedule Of Reverse Recapitalization [Line Items]          
Issued during period, acquisition (in shares) 4,548,687        
Repurchased during period (in shares)   23,051,313      
Common stock, outstanding (in shares) 4,548,687 27,600,000      
Cartesian Growth Corporation (“CGC”) | Director Members          
Schedule Of Reverse Recapitalization [Line Items]          
Issued during period, acquisition (in shares) 30,000        
Cartesian Growth Corporation (“CGC”) | Series A Common stock          
Schedule Of Reverse Recapitalization [Line Items]          
Issued during period, acquisition (in shares) 4,548,687        
Cartesian Growth Corporation (“CGC”) | Series B Common stock          
Schedule Of Reverse Recapitalization [Line Items]          
Issued during period, acquisition (in shares) 0        
Common stock, par value (in usd per share)     $ 0.0001    
Cartesian Growth Corporation (“CGC”) | Cartesian Growth Corporation (“CGC”) Series A Shares (“NRA Shares”)          
Schedule Of Reverse Recapitalization [Line Items]          
Common stock, outstanding (in shares) 3,470,764